Daniel V. Santi

机构：ProLynx (United States) · ORCID：0000-0002-3790-0673

发表论文 498 篇 · 总被引 17754 次 · h-index 68

代表论文

• Long-Acting, Longer-Acting, and Ultralong-Acting Antiobesity Peptides (2025 · Journal of Medicinal Chemistry · 被引 8)
• Pathophysiological and therapeutic implications of C-type natriuretic peptide/cyclic GMP signaling in pulmonary fibrosis (2026 · JCI Insight · 被引 1)
• Antitumor activity of rucaparib plus PLX038A in serous endometrial carcinoma (2025 · Journal of Experimental & Clinical Cancer Research · 被引 1)
• PEG-RLI: A Long-Acting IL-15 Agonist That Produces Massive Levels of CD8+ and CD44hiCD8+ Cells for Cancer Immunotherapy (2026 · Pharmaceutics)
• Supplementary Figure S22 from PET Imaging Using 89Zr-Labeled StarPEG Nanocarriers Reveals Heterogeneous Enhanced Permeability and Retention in Prostate Cancer (2026)
• Supplementary Figure S18 from PET Imaging Using 89Zr-Labeled StarPEG Nanocarriers Reveals Heterogeneous Enhanced Permeability and Retention in Prostate Cancer (2026)